Berberine (vs dihydroberberine)
Summary
Berberine is a plant alkaloid studied mainly for blood lipids and blood sugar. Placebo-controlled meta-analyses show small drops in LDL cholesterol and triglycerides (grade A), mostly from trials in China. It inhibits several drug-metabolizing enzymes in humans, which matters for medication users. Dihydroberberine raised blood berberine more in a five-person pilot.
Key facts
- LDL cholesterol ↓ improved (A); triglycerides ↓ improved (A); blood sugar markers (fasting glucose, HbA1c) ↓ improved (B)[1][2][3]
- Berberine chloride is about 90% berberine by weight (stoichiometry)[10]
- None (botanical); no NIH ODS fact sheet[9]
- Inhibits CYP2D6, CYP2C9 and CYP3A4 in humans; raised cyclosporine levels in transplant recipients[5][6]
- Gastrointestinal effects such as constipation; reported in 2–23% on berberine vs 2–15% on placebo[1][2]
- 2 meta-analyses and 2 randomized trials, plus 2 meta-analyses cited as supporting evidence[1][3][2][4][7][8]
- 4 graded human outcomes on this page
- October 8, 2026
How it works
ProposedHow berberine lowers lipids and glucose in people is not settled. Proposed mechanisms come mainly from cell and animal research and are not covered by the human trials summarized here. Berberine itself is poorly absorbed, which is the rationale offered for dihydroberberine.[4]
What the human research says
Human trials only, one row per outcome. The form column shows what each trial actually tested. Grades follow our evidence-grading policy.
At a glance: strongest evidence per outcome
| Outcome | Grade | Effect | Strongest evidence | Rows |
|---|---|---|---|---|
| Heart | Grade A | Improved | Meta-analysis · n = 1,661 · 2023 | 2 rows |
| Metabolic | Grade B | Improved | RCT · n = 116 · 2008 | 2 rows |
Every graded row
| Outcome | Effect | Grade | Best evidence | PMID |
|---|---|---|---|---|
| Triglycerides | Improved | Grade A | Meta-analysis · n = 1,661 · 2023 18 placebo-controlled RCTs in adults, mostly in China Form: berberine · Dose: Varied across trials · Duration: 4–24 weeks Triglycerides fell by 0.34 mmol/L (about 30 mg/dL) versus placebo. No serious adverse events were reported in the 16 trials that reported them. | 36941490 (opens PubMed)Source [1] |
| LDL cholesterol | Improved | Grade A | Meta-analysis · n = 1,447 · 2023 14 placebo-controlled RCTs in adults (18 trials, n=1,788 overall; 83% in mainland China or Hong Kong) Form: berberine · Dose: Varied across trials · Duration: 4–24 weeks LDL cholesterol fell by 0.46 mmol/L (about 18 mg/dL) versus placebo; total cholesterol fell 0.48 mmol/L and apolipoprotein B 0.25 g/L (2 trials). HDL rose slightly (0.06 mmol/L), in women but not men. | 36941490 (opens PubMed)Source [1] |
| Fasting glucose and HbA1c | Improved | Grade B | RCT · n = 116 · 2008 Adults with type 2 diabetes and dyslipidemia Form: berberine · Dose: 1,000 mg/day · Duration: 3 months Versus placebo, fasting glucose fell from 7.0 to 5.6 mmol/L, HbA1c from 7.5% to 6.6%, with lower triglycerides, total and LDL cholesterol. Mild to moderate constipation in 5 participants on berberine. | 18397984 (opens PubMed)Source [2] |
| Blood berberine levels: dihydroberberine vs berberine | Improved | Grade D | Crossover RCT · n = 5 · 2021 Healthy young men Form: dihydroberberine 100 mg or 200 mg vs berberine 500 mg vs placebo · Dose: 4 doses over about 24 hours of each product · Duration: Single-day crossover conditions Dihydroberberine 100 mg produced higher peak plasma berberine (3.76 vs 0.4 ng/mL) and area under the curve than berberine 500 mg. No differences in glucose or insulin responses. | 35010998 (opens PubMed)Source [4] |
Forms
| Form | Elemental % | Absorption (human data) | GI tolerance | Studied for |
|---|---|---|---|---|
| Berberine hydrochloride (berberine chloride) | 90%[10] | Poorly absorbed; plasma levels after 500 mg were low in the pilot comparison.[4] | Gastrointestinal effects such as constipation are the most reported side effects.[1][2] | LDL cholesterol, triglycerides, glucose and HbA1c, drug-interaction studies |
| Dihydroberberine (DHB) | Varies[10][4] | In a 5-person crossover pilot, 100 mg produced higher plasma berberine than 500 mg berberine.[4] | Marketed for fewer GI effects; no human tolerance comparison data in our sources.[4] | Blood berberine levels only (one pilot); no outcome trials |
Compound weight → elemental active
500 mg berberine hydrochloride (berberine chloride) ≈ 450 mg elemental active
Studied doses
Doses studied in human trials ranged from 600 to 1,000 mg/day of berberine in the trials graded here, usually split into two or three doses, for 2 weeks to 3 months; lipid trials pooled in one meta-analysis lasted 4 to 24 weeks. Dihydroberberine has been studied only at 100–200 mg servings in a one-day pilot.[2][5][6][1][4]
Interactions
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
Medicines
- Drugs cleared by CYP2D6, CYP2C9 or CYP3A4PK studyAfter 2 weeks of berberine 300 mg three times daily in healthy men, CYP2D6 activity fell (dextromethorphan ratio up ninefold), CYP2C9 activity fell (losartan ratio doubled) and midazolam exposure rose about 40%.[5]
- CyclosporineRCTIn kidney-transplant recipients, berberine 200 mg three times daily raised cyclosporine blood levels (trough 29% higher than controls after 3 months; AUC up 34.5% in a 12-day PK study).[6]
Who should be careful
- Pregnancy, breastfeeding and infants
- NCCIH advises that people who are pregnant or breastfeeding should not use goldenseal and that it should not be given to infants, because its berberine constituent can be harmful to newborns.[9]
- People taking prescription medicines
- Berberine inhibits CYP2D6, CYP2C9 and CYP3A4 in humans and raised cyclosporine levels in transplant recipients. Anyone on regular medicines, especially narrow-margin drugs, should check with a pharmacist first.[5][6]
- Diabetes medicines
- Trials found lower glucose and HbA1c, partly in combination with standard medicines. People on glucose-lowering medicines should involve their clinician; berberine has not been tested as a replacement for them.[2][3]
- Digestive side effects
- Gastrointestinal effects, including constipation, were reported more often with berberine than placebo.[1][2]
- Before you start
- Talk to your pharmacist or clinician before adding this supplement, especially if you take prescription medicines, are pregnant or breastfeeding, or have a chronic health condition.[9]
Talk to your pharmacist or clinician before starting a supplement, especially if you take prescription medicines.
Articles about Berberine (vs dihydroberberine)
Plain-English answers to common questions, built on the evidence above.
Frequently asked questions
Is dihydroberberine better than berberine?
It produces higher blood berberine levels per milligram in one tiny study: in 5 men, 100 mg dihydroberberine gave higher plasma berberine than 500 mg berberine, but glucose and insulin responses did not differ. No trials show better health outcomes with dihydroberberine.[4]
How much does berberine lower cholesterol?
Modestly. A 2023 meta-analysis of placebo-controlled trials found LDL about 0.46 mmol/L (roughly 18 mg/dL) lower and triglycerides about 0.34 mmol/L lower. Most trials were short and run in China, and none measured heart events.[1]
Is berberine 'nature's Ozempic'?
That comparison is not supported. Pooled trials show average weight loss under 1 kg (about 0.9 kg), and we found no trials comparing berberine with GLP-1 medicines. Prescription GLP-1 options are a separate category that a clinician manages.[7]
Does berberine interact with medications?
Yes, in human studies. Two weeks of 900 mg/day reduced the activity of CYP2D6, CYP2C9 and CYP3A4 liver enzymes, which clear many common drugs, and berberine raised cyclosporine levels in transplant recipients.[5][6]
What are berberine's side effects?
The most common are digestive: constipation, upset stomach and similar effects, reported in 2–23% of people on berberine versus 2–15% on placebo across trials. No serious adverse events were reported in the trials pooled in a 2023 meta-analysis.[1][2]
Is berberine safe in pregnancy?
No. NCCIH advises against goldenseal during pregnancy and breastfeeding and in infants because berberine can harm newborns.[9]
Sources
- [1]Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.. Drugs, 2023. meta-analysis
- [2]Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine.. J Clin Endocrinol Metab, 2008. RCT
- [3]The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Oxid Med Cell Longev, 2021. meta-analysis
- [4]Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial.. Nutrients, 2021. crossover-RCT
- [5]Repeated administration of berberine inhibits cytochromes P450 in humans.. Eur J Clin Pharmacol, 2012. PK-study
- [6]Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study.. Eur J Clin Pharmacol, 2005. RCT
- [7]The effect of berberine on obesity indices: a systematic review and meta-analysis.. Int J Obes (Lond), 2026. meta-analysis
- [8]Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials.. Front Pharmacol, 2025. meta-analysis
- [9]Goldenseal (berberine constituent; pregnancy, breastfeeding and infants). National Center for Complementary and Integrative Health (NCCIH), 2025. fact-sheet
- [10]Berberine (CID 2353), berberine chloride (CID 12456) and dihydroberberine (CID 10217): molecular weights. PubChem, NCBI, 2026. database
What changed
- First draft. Every evidence-row PMID checked with NCBI E-utilities (esummary + efetch abstract) and re-read in an independent adversarial pass.